- Home
- PDCO vs VERA Comparison
PDCO vs VERA Comparison
Compare PDCO & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDCO
- VERA
- Stock Information
- Founded
- PDCO 1877
- VERA 2016
- Country
- PDCO United States
- VERA United States
- Employees
- PDCO N/A
- VERA N/A
- Industry
- PDCO Medical Specialities
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- PDCO Health Care
- VERA Health Care
- Exchange
- PDCO Nasdaq
- VERA Nasdaq
- Market Cap
- PDCO 2.7B
- VERA 2.7B
- IPO Year
- PDCO 1992
- VERA 2021
- Fundamental
- Price
- PDCO $30.90
- VERA $33.37
- Analyst Decision
- PDCO Hold
- VERA Buy
- Analyst Count
- PDCO 7
- VERA 8
- Target Price
- PDCO $27.10
- VERA $63.50
- AVG Volume (30 Days)
- PDCO 1.6M
- VERA 749.7K
- Earning Date
- PDCO 02-26-2025
- VERA 11-07-2024
- Dividend Yield
- PDCO 3.37%
- VERA N/A
- EPS Growth
- PDCO N/A
- VERA N/A
- EPS
- PDCO 1.72
- VERA N/A
- Revenue
- PDCO $6,554,872,000.00
- VERA N/A
- Revenue This Year
- PDCO $2.81
- VERA N/A
- Revenue Next Year
- PDCO $2.87
- VERA N/A
- P/E Ratio
- PDCO $17.92
- VERA N/A
- Revenue Growth
- PDCO 0.05
- VERA N/A
- 52 Week Low
- PDCO $19.45
- VERA $14.20
- 52 Week High
- PDCO $31.79
- VERA $51.61
- Technical
- Relative Strength Index (RSI)
- PDCO 80.85
- VERA 22.57
- Support Level
- PDCO $30.77
- VERA $31.77
- Resistance Level
- PDCO $30.99
- VERA $36.28
- Average True Range (ATR)
- PDCO 0.09
- VERA 2.18
- MACD
- PDCO -0.34
- VERA -0.86
- Stochastic Oscillator
- PDCO 66.67
- VERA 13.34
About PDCO Patterson Companies Inc.
Patterson Companies Inc is a dental distributor and wholesaler of consumable products and equipment operating through two business segments, Patterson Dental, and Patterson Animal Health. The company's segment includes Dental, Animal Health, and Corporate. It generates maximum revenue from the Animal Health segment. Geographically, it derives its revenue from the United States, the United Kingdom, and Canada. The firm derives almost all of its revenue from the United States.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.